GE HealthCare Technologies Inc. reported a total revenue of $20.6 billion for the fiscal year ending December 31, 2025, reflecting a 4.8% increase compared to the previous year. The company's net income attributable to GE HealthCare was $2.08 billion, a 4.6% rise from $1.99 billion in 2024. Operating income also saw an increase, reaching $2.76 billion, up from $2.63 billion in the prior year. The growth in revenue was primarily driven by strong performances in the Pharmaceutical Diagnostics (PDx) and Imaging segments, which reported revenue increases of 15.6% and 4.4%, respectively.
The company experienced notable changes in its financial performance, particularly in its segment revenues. The Imaging segment generated $9.25 billion, while the Advanced Visualization Solutions (AVS) segment brought in $5.35 billion, both showing growth despite challenges in the China market. The Patient Care Solutions (PCS) segment, however, saw a slight decline of 1.2% to $3.09 billion, attributed to decreased revenues in Life Support Solutions. The overall revenue growth was also supported by a 5.6% increase in service sales, totaling $6.96 billion.
Strategically, GE HealthCare has been active in expanding its portfolio through acquisitions. In 2025, the company acquired the remaining 50% interest in Nihon Medi-Physics Co., Ltd. for $271 million, enhancing its capabilities in radiopharmaceuticals. Additionally, the company announced a proposed acquisition of Intelerad for $2.3 billion, aimed at bolstering its medical imaging software and digital enterprise workflow solutions. These acquisitions are expected to enhance GE HealthCare's offerings and market position in the healthcare technology sector.
Operationally, GE HealthCare serves customers in over 160 countries, supported by a workforce of approximately 54,000 employees. The company reported a significant increase in cash and cash equivalents, totaling $4.51 billion as of December 31, 2025, up from $2.89 billion the previous year. The company also maintained a strong focus on research and development, investing $1.26 billion in 2025, which is crucial for sustaining innovation in its product lines. The company’s employee headcount remained stable, reflecting its commitment to maintaining a skilled workforce amid ongoing market challenges.
Looking ahead, GE HealthCare anticipates continued growth driven by its strategic investments in cloud, AI, and software solutions, despite potential risks from geopolitical tensions and economic instability. The company is closely monitoring market conditions, particularly in China and other regions affected by trade policies and tariffs, which have already impacted its financial results. The management remains optimistic about leveraging its acquisitions and expanding its product offerings to enhance customer engagement and drive sustainable growth in the healthcare technology market.
About GE HealthCare Technologies Inc.
GE Healthcare Technologies Inc. is a global provider of medical imaging, diagnostic, and patient monitoring equipment, along with digital and AI-enabled healthcare solutions. Its core segments include Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Serving healthcare providers worldwide, the company focuses on precision medicine, clinical decision support, and improving patient outcomes through innovative technology, comprehensive services, and a broad product portfolio.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.